Abstract
The reported primary dementia-protective benefits of angiotensin II type 1 receptor (AT1R) blockers (ARB) are believed, at least in part, to arise from systemic effects on blood pressure. However, there is a specific and independently regulated brain renin-angiotensin system (RAS). Brain RAS acts mainly through three receptor subtypes; AT1R, AT2R, and AT4R. The AT1R promotes inflammation and mitochondrial reactive oxygen species generation. AT2R increases nitric oxide. AT4R is essential for dopamine and acetylcholine release. It is unknown whether ARB use is associated with changes in the brain RAS. Here, we compared the impact of treatment with ARB on not cognitively impaired individuals and individuals with Alzheimer’s dementia using postmortem frontal-cortex samples of age- and sex-matched participants (70–90 years old, n = 30 in each group). We show that ARB use is associated with higher brain AT4R, lower oxidative stress, and amyloid-β burden in NCI participants. In AD, ARB use was associated with lower brain AT1R but had no impact on inflammation, oxidative stress, or amyloid-β burden. Our results may suggest a potential role for AT4R in the salutary effects for ARB on the brains of not cognitively impaired older adults.
Graphical abstract
Similar content being viewed by others
References
James BD, Bennett DA. Annu Rev Public Health. 2019;40:65–84.
K.B. Rajan, J. Weuve, L.L. Barnes, E.A. McAninch, R.S. Wilson, D.A. Evans, Alzheimers Dement. J. Alzheimers Assoc. (2021).
Albers DS, Beal MF. J Neural Transm Suppl. 2000;59:133–54.
Yin F, Sancheti H, Patil I, Cadenas E. Free Radic Biol Med. 2016;100:108.
C. Cosarderelioglu, L. Nidadavolu, C. George, E. Oh, D.A. Bennett, J.D. Walston, P. Abadir, Front. Neurosci. 14 (2020).
J.L. Labandeira-Garcia, A.I. Rodríguez-Perez, P. Garrido-Gil, J. Rodriguez-Pallares, J.L. Lanciego, M.J. Guerra, Front. Aging Neurosci. 9 (2017).
Wright JW, Harding JW. J Alzheimers Dis. 2019;67:469–80.
Zhu D, Shi J, Zhang Y, Wang B, Liu W, Chen Z, Tong Q. PLoS ONE. 2011;6:e16037.
Jackson L, Eldahshan W, Fagan S, Ergul A. Int J Mol Sci. 2018;19:876.
Abadir PM, Carey RM, Siragy HM. Hypertens Dallas Tex. 2003;1979(42):600–4.
Wright JW, Harding JW. J Renin Angiotensin Aldosterone Syst. 2008;9:226–37.
R. Vajapey, D. Rini, J. Walston, P. Abadir, Front. Physiol. 5 (2014).
T.M. De Silva, F.M. Faraci, Front. Physiol. 3 (2013).
Wright JW, Harding JW. J Alzheimers Dis JAD. 2019;67:469–80.
C. Cosarderelioglu, L.S. Nidadavolu, C.J. George, R. Marx, L. Powell, Q.-L. Xue, J. Tian, J. Salib, E. Oh, L. Ferrucci, P. Dincer, D.A. Bennett, J.D. Walston, P.M. Abadir, J. Gerontol. Ser. A (2021) glab376.
Bennett DA, Buchman AS, Boyle PA, Barnes LL, Wilson RS, Schneider JA. J Alzheimers Dis JAD. 2018;64:S161–89.
Bennett DA, Buchman AS, Barnes LL, Boyle PA, Wilson RS. Curr Alzheimer Res. 2012;9:646–63.
Colurso GJ, Nilson JE, Vervoort LG. Life Sci. 2003;73:1795–803.
Diaz-Ruiz C, Villar-Cheda B, Dominguez-Meijide A, Garrido-Gil P, Guerra MJ, Labandeira-Garcia JL. J Gerontol Ser A. 2020;75:416–24.
Abadir PM, Foster DB, Crow M, Cooke CA, Rucker JJ, Jain A, Smith BJ, Burks TN, Cohn RD, Fedarko NS, Carey RM, O’Rourke B, Walston JD. Proc Natl Acad Sci. 2011;108:14849–54.
Garcia-Garrote M, Perez-Villalba A, Garrido-Gil P, Belenguer G, Parga JA, Perez-Sanchez F, Labandeira-Garcia JL, Fariñas I, Rodriguez-Pallares J. Cells. 2019;8:1551.
Drobin K, Assadi G, Hong M-G, Andersson E, Fredolini C, Forsström B, Reznichenko A, Akhter T, Ek WE, Bonfiglio F, Hansen MB, Sandberg K, Greco D, Repsilber D, Schwenk JM, D’Amato M, Halfvarson J. Inflamm Bowel Dis. 2019;25:306–16.
Valenzuela R, Costa-Besada MA, Iglesias-Gonzalez J, Perez-Costas E, Villar-Cheda B, Garrido-Gil P, Melendez-Ferro M, Soto-Otero R, Lanciego JL, Henrion D, Franco R, Labandeira-Garcia JL. Cell Death Dis. 2016;7:e2427.
Franco R, Lillo A, Rivas-Santisteban R, Rodríguez-Pérez AI, Reyes-Resina I, Labandeira-García JL, Navarro G. Int J Mol Sci. 2020;21:E9602.
Fernando RN, Larm J, Albiston AL, Chai SY. J Comp Neurol. 2005;487:372–90.
Keller SR, Scott HM, Mastick CC, Aebersold R, Lienhard GE. J Biol Chem. 1995;270:23612–8.
Zhang J-H, Hanesworth JM, Sardinia MF, Alt JA, Wright JW, Harding JW. J Pharmacol Exp Ther. 1999;289:1075–83.
Maity-Kumar G, Thal DR, Baumann B, Scharffetter-Kochanek K, Wirth T. FASEB J. 2015;29:2843–58.
Bennett DA, Schneider JA, Buchman AS, Barnes LL, Boyle PA, Wilson RS. Curr Alzheimer Res. 2012;9:646–63.
Wilson RS, Boyle PA, Yu L, Barnes LL, Sytsma J, Buchman AS, Bennett DA, Schneider JA. Neurology. 2015;85:984–91.
P.L. De Jager, J.M. Shulman, L.B. Chibnik, B.T. Keenan, T. Raj, R.S. Wilson, L. Yu, S.E. Leurgans, D. Tran, C. Aubin, C.D. Anderson, A. Biffi, J.J. Corneveaux, M.J. Huentelman, Alzheimer’s disease neuroimaging initiative, J. Rosand, M.J. Daly, A.J. Myers, E.M. Reiman, D.A. Bennett, D.A. Evans, Neurobiol. Aging 33 (2012) 1017.e1–15.
Jansen WJ, Wilson RS, Visser PJ, Nag S, Schneider JA, James BD, Leurgans SE, Capuano AW, Bennett DA, Boyle PA. Neurobiol Aging. 2018;61:138–45.
Buchman AS, Boyle PA, Leurgans SE, Evans DA, Bennett DA. Proc Am Thorac Soc. 2009;6:581–7.
Buchman AS, Shah RC, Leurgans SE, Boyle PA, Wilson RS, Bennett DA. Arthritis Care Res. 2010;62:1287–93.
Wright JW, Kawas LH, Harding JW. Prog Neurobiol. 2015;125:26–46.
Baierle M, Nascimento SN, Moro AM, Brucker N, Freitas F, Gauer B, Durgante J, Bordignon S, Zibetti M, Trentini CM, Duarte MMMF, Grune T, Breusing N, Garcia SC. Oxid Med Cell Longev. 2015;2015:e804198.
Braszko JJ, Walesiuk A, Wielgat P. J Renin Angiotensin Aldosterone Syst. 2006;7:168–74.
Royea J, Zhang L, Tong X-K, Hamel E. J Neurosci. 2017;37:5562–73.
Takeda S, Sato N, Takeuchi D, Kurinami H, Shinohara M, Niisato K, Kano M, Ogihara T, Rakugi H, Morishita R. Hypertens Dallas Tex. 2009;1979(54):1345–52.
Saavedra JM. Cell Mol Neurobiol. 2016;36:259–79.
Ongali B, Nicolakakis N, Tong X-K, Aboulkassim T, Papadopoulos P, Rosa-Neto P, Lecrux C, Imboden H, Hamel E. Neurobiol Dis. 2014;68:126–36.
Royea J, Martinot P, Hamel E. Neurobiol Dis. 2020;134:104644.
Drews HJ, Yenkoyan K, Lourhmati A, Buadze M, Kabisch D, Verleysdonk S, Petschak S, Beer-Hammer S, Davtyan T, Frey WH, Gleiter CH, Schwab M, Danielyan L. Neurotherapeutics. 2019;16:725–40.
Wang J, Ho L, Chen L, Zhao Z, Zhao W, Qian X, Humala N, Seror I, Bartholomew S, Rosendorff C, Pasinetti GM. J Clin Invest. 2007;117:3393–402.
Benson Stephen C., Pershadsingh Harrihar A., Ho Christopher I., Chittiboyina Amar, Desai Prashant, Pravenec Michal, Qi Nianning, Wang Jiaming, Avery Mitchell A., Kurtz Theodore W., Hypertension 43 (2004) 993–1002.
M.O. Grimm, J. Mett, C.P. Stahlmann, V.J. Haupenthal, V.C. Zimmer, T. Hartmann, Front. Aging Neurosci. 5 (2013).
Ouk M, Wu C-Y, Rabin JS, Edwards JD, Ramirez J, Masellis M, Swartz RH, Herrmann N, Lanctôt KL, Black SE, Swardfager W. Neurobiol Aging. 2021;100:22–31.
Danielyan L, Klein R, Hanson LR, Buadze M, Schwab M, Gleiter CH, Frey WH. Rejuvenation Res. 2010;13:195–201.
Mogi M, Li J-M, Tsukuda K, Iwanami J, Min L-J, Sakata A, Fujita T, Iwai M, Horiuchi M. Biochem Biophys Res Commun. 2008;375:446–9.
Hajjar I, Brown L, Mack WJ, Chui H. Arch Neurol. 2012;69:1632–8.
Pang T, Benicky J, Wang J, Orecna M, Sanchez-Lemus E, Saavedra JM. J Hypertens. 2012;30:87–96.
Benicky J, Sánchez-Lemus E, Honda M, Pang T, Orecna M, Wang J, Leng Y, Chuang D-M, Saavedra JM. Neuropsychopharmacology. 2011;36:857–70.
Xu Y, Xu Y, Wang Y, Wang Y, He L, Jiang Z, Huang Z, Liao H, Li J, Saavedra JM, Zhang L, Pang T. Brain Behav Immun. 2015;50:298–313.
Wang Q-G, Xue X, Yang Y, Gong P-Y, Jiang T, Zhang Y-D. J Renin Angiotensin Aldosterone Syst. 2018;19:1470320318799587.
J.L. Labandeira-Garcia, R. Valenzuela, M.A. Costa-Besada, B. Villar-Cheda, A.I. Rodriguez-Perez, Prog. Neurobiol. (2020).
Benicky J, Hafko R, Sanchez-Lemus E, Aguilera G, Saavedra JM. Cell Mol Neurobiol. 2012;32:1353–65.
Herrera M, Sparks MA, Alfonso-Pecchio AR, Harrison-Bernard LM, Coffman TM. Hypertension. 2013;61:253–8.
Hafko R, Villapol S, Nostramo R, Symes A, Sabban EL, Inagami T, Saavedra JM. PLoS ONE. 2013;8: e69234.
R.L. Levine, J.A. Williams, E.P. Stadtman, E. Shacter, in: Methods Enzymol., Academic Press, 1994, pp. 346–357.
Grune T, Jung T, Merker K, Davies KJA. Int J Biochem Cell Biol. 2004;36:2519–30.
Brioschi M, Polvani G, Fratto P, Parolari A, Agostoni P, Tremoli E, Banfi C. PLoS ONE. 2012;7:e35841.
Weber D, Stuetz W, Toussaint O, Debacq-Chainiaux F, Dollé MET, Jansen E, Gonos ES, Franceschi C, Sikora E, Hervonen A, Breusing N, Sindlinger T, Moreno-Villanueva M, Bürkle A, Grune T. Oxid Med Cell Longev. 2017;2017:e1401452.
Di Domenico F, Coccia R, Butterfield DA, Perluigi M. Biochim. Biophys Acta BBA - Proteins Proteomics. 1814;2011:1785–95.
Jung T, Engels M, Klotz L-O, Kröncke K-D, Grune T. Free Radic Biol Med. 2007;42:773–86.
Lopez-Real A, Rey P, Soto-Otero R, Mendez-Alvarez E, Labandeira-Garcia JL. J Neurosci Res. 2005;81:865–73.
Ding Q, Shults NV, Gychka SG, Harris BT, Suzuki YJ. Int J Mol Sci. 2021;22:1687.
Muñoz A, Rey P, Guerra MJ, Mendez-Alvarez E, Soto-Otero R, Labandeira-Garcia JL. Neuropharmacology. 2006;51:112–20.
Sparks DL, Scheff SW, Liu H, Landers TM, Coyne CM, Hunsaker JC. J Neurol Sci. 1995;131:162–9.
Ashby EL, Miners JS, Kehoe PG, Love S. J Alzheimers Dis. 2016;50:1191–203.
Walker KA, Power MC, Gottesman RF. Curr Hypertens Rep. 2017;19:24.
T.J. Oscanoa, J. Amado, X. Vidal, R. Romero-Ortuno, Curr. Clin. Pharmacol. (2020).
Scotti L, Bassi L, Soranna D, Verde F, Silani V, Torsello A, Parati G, Zambon A. Pharmacol Res. 2021;166:105515.
Acknowledgements
Figure 7 was created with BioRender.com.
Funding
This work was supported by the Bright Focus Foundation Research Award (PMA), the Johns Hopkins University Claude D. Pepper Older Americans Independence Center, which is funded by the National Institute on Aging of the National Institutes of Health under award number P30AG021334 and NIH Grants R01AG046441 and K23 AG035005, and R01AG17917; and the Nathan W. and Margaret T. Shock Aging Research Foundation, Nathan Shock Scholar in Aging (PMA). This research was supported in part by the Intramural Research Program at the National Institute on Aging. Its contents are solely the authors’ responsibility and do not necessarily represent the official view of the NIH.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no competing interests.
Additional information
This manuscript does not contain material previously published and is not under consideration for publication elsewhere, in whole or in part. Every author listed on our manuscript meets the qualification for authorship and has had the opportunity to read and comment upon the submitted manuscript.
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
About this article
Cite this article
Cosarderelioglu, C., Nidadavolu, L.S., George, C.J. et al. Angiotensin receptor blocker use is associated with upregulation of the memory-protective angiotensin type 4 receptor (AT4R) in the postmortem brains of individuals without cognitive impairment. GeroScience 45, 371–384 (2023). https://doi.org/10.1007/s11357-022-00639-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11357-022-00639-8